Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol

Biochem Biophys Res Commun. 2006 Sep 15;348(1):170-5. doi: 10.1016/j.bbrc.2006.07.029. Epub 2006 Jul 14.

Abstract

As high telomerase activity is detected in most cancer cells, inhibition of telomerase by drug or dietary food components is a new strategy for cancer prevention. Here, we investigated the inhibitory effect of vitamin E, with particular emphasis on tocotrienol (unsaturated vitamin E), on human telomerase in cell-culture study. As results, tocotrienol inhibited telomerase activity of DLD-1 human colorectal adenocarcinoma cells in time- and dose-dependent manner, interestingly, with delta-tocotrienol exhibiting the highest inhibitory activity. Tocotrienol inhibited protein kinase C activity, resulting in down-regulation of c-myc and human telomerase reverse transcriptase (hTERT) expression, thereby reducing telomerase activity. In contrast to tocotrienol, tocopherol showed very weak telomerase inhibition. These results provide novel evidence for the first time indicating that tocotrienol acts as a potent candidate regulator of telomerase and supporting the anti-proliferative function of tocotrienol.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / enzymology
  • Antioxidants / pharmacology
  • Cell Line, Tumor
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / enzymology
  • DNA-Binding Proteins / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Enzyme Activation / drug effects
  • Humans
  • Proto-Oncogene Proteins c-myc / antagonists & inhibitors
  • Telomerase / antagonists & inhibitors*
  • Tocotrienols / pharmacology*

Substances

  • Antioxidants
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins c-myc
  • Tocotrienols
  • Telomerase